20
Participants
Start Date
May 1, 2019
Primary Completion Date
December 1, 2019
Study Completion Date
May 1, 2020
Brodalumab
"Brodalumab is a human monoclonal IgG2κ antibody directed against human interleukin-17 receptor A (IL-17RA). It is expressed in a Chinese Hamster Ovary (CHO) cell line. Brodalumab is comprised of 1312 amino acids and has an estimated molecular mass of 144,000 Daltons.~Brodalumab Injection is a sterile, preservative-free, yellow solution, delivered via subcutaneous injection. . Each Brodalumab single dose prefilled syringe delivers 1.5 mL of solution containing 210 mg of brodalumab formulated in glutamate (6.5 mg), polysorbate 20 (0.15 mg), proline (36 mg), and Water for Injection, USP at pH 4.8."
Florida Academic Centers Research and Education, LLC, Coral Gables
Collaborators (1)
Ortho Dermatologics
INDUSTRY
Florida Academic Dermatology Centers
OTHER